Gut Microbiota Research & Practice is a section dedicated to promoting knowledge-sharing and debate among researchers, scientists and healthcare professionals. You will find a selection of discussions about articles from scientific literature as well as other content including interviews with experts, event reports, and special publications.

Study identifies a role for bacterial proteases in Crohn’s disease

26 Jun 2023

by Amber Hann, Heather Galipeau

Inflammatory bowel disease is a chronic remitting and relapsing condition that causes severe inflammation of the intestines and disabling bowel symptoms. It affects millions of lives globally, and although alterations in the gut microbiome have been associated with IBD, precise mechanisms remain incompletely understood. New research from McMaster University now implicates bacterial proteases in Crohn’s disease.

Probiotics are commonly used in clinical practice for digestive ailments. Some clinical trials also support the use of specific probiotics, taken orally or vaginally, for restoring the vaginal microbiota and managing bacterial vaginosis and vulvovaginal candidiasis. Here’s what we know.

While fecal microbiota transplants are recommended for multiple recurrent Clostridioides difficile infection, their use in clinical practice is hindered by a lack of regulation and understanding of the underlying ecological dynamics. This article covers major challenges for the treatment in transitioning from bench to bedside, from the scientific, clinical and regulatory perspectives (Part 6).

It has been 10 years since GMFH was launched with the aim of disseminating the latest gut microbiome research to the lay public, healthcare professionals and scientists alike. In this article, members of the GMFH board of experts share their pick of the most significant advances in the field, outlining their clinical impact and implications for further research.

Go to Top